Carolyn Tang
2021
Compensation breakdown
| Non-Equity Incentive Plan | $200,000 |
|---|---|
| Option Awards | $1,852,686 |
| Salary | $400,000 |
| Stock Awards | $460,521 |
| Other | $3,200 |
| Total | $2,916,407 |
Tang received $1.9M in option awards, accounting for 64% of the total pay in 2021.
Tang also received $200K in non-equity incentive plan, $400K in salary, $460.5K in stock awards and $3.2K in other compensation.
Rankings
In 2021, Carolyn Tang's compensation ranked 4,535th out of 12,406 executives tracked by ExecPay. In other words, Tang earned more than 63.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,535 out of 12,406 | 63rd |
Division Manufacturing | 1,874 out of 5,492 | 66th |
Major group Chemicals And Allied Products | 779 out of 2,368 | 67th |
Industry group Drugs | 693 out of 2,089 | 67th |
Industry Pharmaceutical Preparations | 494 out of 1,536 | 68th |
Pay ratio
| Carolyn Tang's Pay | $2,916,407 |
|---|---|
| Median Employee's Pay | $296,616 |
| Pay Ratio | 10to 1 |
In 2021, the annual total compensation of Carolyn Tang was $2,916,407.
The annual total compensation of the median employee at Arcus Biosciences was $296,616.
The ratio of Carolyn Tang's pay to the pay of median employee was therefore 10 to one.
Tang's colleagues
We found five more compensation records of executives who worked with Carolyn Tang at Arcus Biosciences in 2021.
2021
Jennifer Jarrett
Arcus Biosciences
Chief Operating Officer
2021
Terry Rosen
Arcus Biosciences
Chief Executive Officer
2021
Juan Jaen
Arcus Biosciences
President and Director
2021
William Grossman
Arcus Biosciences
Chief Medical Officer
2021
Robert Goeltz
Arcus Biosciences